Stock Market & Financial Investment News

Life Technologies announces SFDA clearance for 3500xL Dx Genetic AnalyzerLife Technologies announced that its Applied Biosystems 3500xL Dx Genetic Analyzer has been approved by China's State Food and Drug Administration, or SFDA, for clinical diagnostic use in China and the launch of 10 Assays from its joint venture with Daan Gene. Based on the 3500 Dx series platform, ten assays have been developed or licensed by Guangzhou Life Technologies DaAn Diagnostics, a joint venture between Life Technologies and Daan Gene of Sun Yat Sen University. Currently, nine out of the ten assays are Research Use Only kits and the other one that can be used in Trisomy 21 prenatal screening for Down syndrome is SFDA registered. The company is currently conducting clinical trials and is actively seeking the SFDA approval for the remaining nine kits.